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Introduction
Cryopyrin-associated periodic syndromes (CAPS) are a
group of dominantly inherited disorders caused by gain-
of-function NLRP3 mutations. These disorders represent
different degrees of severity of a same disease being
familial cold autoinflammatory syndrome the milder
form, Muckle-Wells syndrome an intermediate form and
chronic infantile neurologic cutaneous and articular syn-
drome the severest form. Overlapping phenotypes among
these diseases have been also reported. Here we describe
two different Spanish families with atypical presentation
for CAPS. The initial NLRP3 screening, which only
included the analysis of exon 3, was negative. However,
the complete gene analysis revealed two novel missense
mutations in exon 1 and 8, respectively.
Case Report
The patient 1 is a 36 year-old woman who suffered from
recurrent episodes of uveitis since 2011 and from progres-
sive neurosensorial hypoacusia. She did not refer other
symptoms related to CAPS. There was familial history of
hypoacusia in her sister, mother and maternal grand-
mother, suggesting a dominant inheritance pattern for this
trait. The NLRP3 analyses revealed a heterozygous A-to-G
transition in the exon 1 of NLRP3 (at c.146 position),
which provokes the missense histidine-to-arginine variant
at residue 49 (p.H49R) of cryopyrin .
The propositus of second family is an adult man who
referred a pharmacological allergy, and a skin rash in
hands, arms and auricular pavilions that apparently
appeared in winter and after cold exposure. These data
suggested to perform a NLRP3 analysis that revealed a het-
erozygous point C-to-T transition at c.2885 nucleotide
position, on the exon 8, that provokes the threonine to
metionine amino acid change in residue 952 (p.T952M) of
cryopyrin.
Discussion
Most of disease-causing NLRP3 mutations are located on
the exon 3. Here we describe two novel NLRP3 mutations
located on exons 1 and 8, that were identified in patients
with atypical presentations for CAPS. In the first family,
the detected missense p.H49R mutation represents the
first detected mutation identified in the exon 1 of the
gene, affecting the PYD domain of cryopyrin. Interestingly,
the patient with this mutation was affected by recurrent
episodes of uveitis and neurosensorial hypoacusia that
appeared during the adulthood, with no other clinical fea-
tures of CAPS. In the second family, the p.T952M muta-
tion was detected on the exon 8 of the NLRP3 gene and
represents the first and unique mutation identified to date
in this exon. These cases highlight the relevance to per-
form a complete NLRP3 analyses in potential candidates,
including those patients that could refer atypical presenta-
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